Cargando…
It is time to end our love affair with short-acting β(2)-agonists in asthma
In this issue of ERJOR, Noorduyn et al. add data to the growing literature showing that SABA overuse in asthma is both common and associated with severe exacerbations. It is time to take note and act to tackle this global issue. https://bit.ly/3BfwhfS
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574554/ https://www.ncbi.nlm.nih.gov/pubmed/36267894 http://dx.doi.org/10.1183/23120541.00353-2022 |
| _version_ | 1784811127201333248 |
|---|---|
| author | Crooks, Michael G. Faruqi, Shoaib |
| author_facet | Crooks, Michael G. Faruqi, Shoaib |
| author_sort | Crooks, Michael G. |
| collection | PubMed |
| description | In this issue of ERJOR, Noorduyn et al. add data to the growing literature showing that SABA overuse in asthma is both common and associated with severe exacerbations. It is time to take note and act to tackle this global issue. https://bit.ly/3BfwhfS |
| format | Online Article Text |
| id | pubmed-9574554 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95745542022-10-19 It is time to end our love affair with short-acting β(2)-agonists in asthma Crooks, Michael G. Faruqi, Shoaib ERJ Open Res Editorials In this issue of ERJOR, Noorduyn et al. add data to the growing literature showing that SABA overuse in asthma is both common and associated with severe exacerbations. It is time to take note and act to tackle this global issue. https://bit.ly/3BfwhfS European Respiratory Society 2022-10-17 /pmc/articles/PMC9574554/ /pubmed/36267894 http://dx.doi.org/10.1183/23120541.00353-2022 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
| spellingShingle | Editorials Crooks, Michael G. Faruqi, Shoaib It is time to end our love affair with short-acting β(2)-agonists in asthma |
| title | It is time to end our love affair with short-acting β(2)-agonists in asthma |
| title_full | It is time to end our love affair with short-acting β(2)-agonists in asthma |
| title_fullStr | It is time to end our love affair with short-acting β(2)-agonists in asthma |
| title_full_unstemmed | It is time to end our love affair with short-acting β(2)-agonists in asthma |
| title_short | It is time to end our love affair with short-acting β(2)-agonists in asthma |
| title_sort | it is time to end our love affair with short-acting β(2)-agonists in asthma |
| topic | Editorials |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574554/ https://www.ncbi.nlm.nih.gov/pubmed/36267894 http://dx.doi.org/10.1183/23120541.00353-2022 |
| work_keys_str_mv | AT crooksmichaelg itistimetoendourloveaffairwithshortactingb2agonistsinasthma AT faruqishoaib itistimetoendourloveaffairwithshortactingb2agonistsinasthma |